This inventor holds 1 USPTO granted patent. Top assignee: Innogenetics N.v.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Fabienne Hemmen: Innovator in Brucella Diagnostics
Introduction
Fabienne Hemmen is a notable inventor based in Meudon, France. She has made significant contributions to the field of diagnostics, particularly in relation to Brucella infections. Her work has implications for both diagnostic and prophylactic methods, showcasing her commitment to advancing medical science.
Latest Patents
Hemmen holds a patent for the invention titled "17-KDA Brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits." This patent describes an isolated 17-kDa Brucella antigen characterized by an amino acid sequence with at least 60% homology to specific sequences. The antigen is recognized by sera from individuals infected with Brucella, making it a valuable tool for diagnostics.
Career Highlights
Fabienne Hemmen is associated with Innogenetics N.V., where she has been instrumental in developing innovative solutions for infectious disease diagnostics. Her expertise in recombinant technology has positioned her as a key player in her field.
Collaborations
Hemmen collaborates with Eric Saman, contributing to the advancement of research and development in their shared field of expertise.
Conclusion
Fabienne Hemmen's work exemplifies the intersection of innovation and healthcare, particularly in the fight against Brucella infections. Her contributions through patents and collaboration continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
